Patent · US Active

Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages

US11873489B2 · kind B2 · utility

0Cited by

3References

14Claims

0Family size

Assignee

Sapience Therapeutics, Inc. · DE

Inventors

Lucas Bethge · Potsdam, DE
Judith Hauptmann · Berlin, DE
Christian Frauendorf · Berlin, DE
Adrien Weingärtner · Berlin, DE

Key dates

Filing date	Nov 13, 2018
Grant date	Jan 16, 2024
Priority date	—
Expiry date	Jun 23, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2330/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.